Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma

G. Hunsmann, Niels C Pedersen, G. H. Theilen, H. Bayer

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

The efficiency was examined of immunization with feline leukemia virus glycoprotein complexes (gp85 rosettes) to protect cats against tumors induced by feline sarcoma virus (FeSV). The glycoprotein was isolated from feline leukemia virus (FeLV). Young cats were vaccinated with the purified viral glycoprotein and challenged with FeSV (FeLV). FeLV gp85 antibody levels were measured by enzyme-linked immunosorbent assay and tumor volumes were determined. In immunized animals tumor development was reduced. Gp85 antibody levels before challenge were correlated inversely with tumor size (r2=0.79). This method appears to be suitable for fast and efficient testing of future FeLV vaccines.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalMedical Microbiology and Immunology
Volume171
Issue number4
DOIs
StatePublished - Mar 1983

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma'. Together they form a unique fingerprint.

  • Cite this